Trends in biological joint resurfacing

被引:9
作者
Myers, K. R. [1 ]
Sgaglione, N. A. [1 ]
Grande, D. A. [2 ]
机构
[1] North Shore Univ Hospital, Long Isl Jewish Med Ctr, Dept Orthopaed, New York, NY 11040 USA
[2] Feinstein Inst Med Res, Orthopaed Res Lab, Manhasset, NY 11030 USA
关键词
Cartilage regeneration; Biological joint resurfacing; Regenerative medicine; Stem cells; Tissue engineering; Orthopaedic surgery; MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; TISSUE-ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE; OSTEOCHONDRAL DEFECTS; KNEE OSTEOARTHRITIS; REPAIR; REGENERATION; LESIONS; MODEL;
D O I
10.1302/2046-3758.29.2000189
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The treatment of osteochondral lesions and osteoarthritis remains an ongoing clinical challenge in orthopaedics. This review examines the current research in the fields of cartilage regeneration, osteochondral defect treatment, and biological joint resurfacing, and reports on the results of clinical and pre-clinical studies. We also report on novel treatment strategies and discuss their potential promise or pitfalls. Current focus involves the use of a scaffold providing mechanical support with the addition of chondrocytes or mesenchymal stem cells (MSCs), or the use of cell homing to differentiate the organism's own endogenous cell sources into cartilage. This method is usually performed with scaffolds that have been coated with a chemotactic agent or with structures that support the sustained release of growth factors or other chondroinductive agents. We also discuss unique methods and designs for cell homing and scaffold production, and improvements in biological joint resurfacing. There have been a number of exciting new studies and techniques developed that aim to repair or restore osteochondral lesions and to treat larger defects or the entire articular surface. The concept of a biological total joint replacement appears to have much potential.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 65 条
[1]   A comparison of fibrin, agarose and gellan gum hydrogels as carriers of stem cells and growth factor delivery microspheres for cartilage regeneration [J].
Ahearne, Mark ;
Kelly, Daniel J. .
BIOMEDICAL MATERIALS, 2013, 8 (03)
[2]  
[Anonymous], KNEE SURG SPORTS TRA
[3]  
Chadha N, P ORS 2012 SAN FRANC
[4]  
Chinitz N, AM AC ORTH SURG 2013
[5]   NeoCart, an Autologous Cartilage Tissue Implant, Compared with Microfracture for Treatment of Distal Femoral Cartilage Lesions An FDA Phase-II Prospective, Randomized Clinical Trial After Two Years [J].
Crawford, Dennis C. ;
DeBerardino, Thomas M. ;
Williams, Riley J., III .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (11) :979-989
[6]  
Datta A, 2013, P SOC BIOM BOST APR
[7]   A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells [J].
De Bari, Cosimo ;
Dell'Accio, Francesco ;
Karystinou, Alexandra ;
Guillot, Pascale V. ;
Fisk, Nicholas M. ;
Jones, Elena A. ;
McGonagle, Dennis ;
Khan, Ilyas M. ;
Archer, Charles W. ;
Mitsiadis, Thimios A. ;
Donaldson, Ana Nora ;
Luyten, Frank P. ;
Pitzalis, Costantino .
ARTHRITIS AND RHEUMATISM, 2008, 58 (01) :240-250
[8]  
Detterline Alvin J, 2008, J Knee Surg, V21, P106
[9]   Healing full-thickness cartilage defects using adipose-derived stem cells [J].
Dragoo, Jason L. ;
Carlson, Grace ;
McCormick, Frank ;
Khan-Farooqi, Haumith ;
Zhu, Min ;
Zuk, Patricia A. ;
Benhaim, Prosper .
TISSUE ENGINEERING, 2007, 13 (07) :1615-1621
[10]  
Durney KM, 2011, MICROBUBBLES IMPROVE